… and improved treatment options [2]. However, this trend is not seen in inflammatory bowel
disease-related CRC (IBD-CRC), specifically ulcerative colitis (UC) and Crohn’s disease (CD) …

… have been implicated to play a role in the pathogenesis of inflammatory bowel disease (IBD),
possibly by interacting with gut microbiota and the mucosal immune system. The role of …

… against pathogenic cytokines or chemokines have provided treatment opportunities for …
Additionally, T reg cells may provide a more effective therapy for IBD; therefore the unknown …

… Epidemiological surveys indicate that the incidence of inflammatory bowel disease (IBD)
is increasing rapidly with the continuous growth of the economy. A large number of studies …

… IBD is a complex, chronic, immune-mediated condition primarily of the gastrointestinal …
pathophysiology is evolving, and with that are opportunities to further explore other therapeutic …

… of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel
disease. … of oxidative stress in inflammatory bowel disease and potential antioxidant therapies. …

… Research in the inflammatory bowel disease (IBD) field is considered one of the most
relevant challenges of modern gastroenterology. IBD is becoming more well recognized as a …

… In this Review, we discuss the available data on the role of diet in the pathogenesis of IBD
with a focus on epidemiological, gene–environment interaction, intervention, gut microbiome …

… The pathogenesis of inflammatory bowel disease (IBD) is complex and multifactorial.
Undertreated disease has substantial individual and societal consequences. Current patient …

… The incidence and prevalence rates of inflammatory bowel disease (IBD) have been
increasing in East Asian countries over the past few decades. Accordingly, the general …